Astrazeneca (AZN) Change in Taxes (2015 - 2026)

Astrazeneca (AZN) has reported Change in Taxes for 9 consecutive years, with -$526.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Taxes fell 44.9% year-over-year to -$526.0 million; the TTM figure through Mar 2026 stood at -$4.3 billion (up 27.38% YoY), while the FY2025 annual figure was -$2.8 billion, down 3.45% from the prior year.
• Change in Taxes came in at -$526.0 million for Q1 2026 at Astrazeneca, up from -$652.0 million in the prior quarter.
• The five-year high for Change in Taxes was -$225.0 million in Q1 2023, with the low at -$2.8 billion in Q4 2024.
• Average Change in Taxes over 5 years is -$986.1 million, with a median of -$526.0 million recorded in 2026.
• Across the five-year window, Change in Taxes sank 91.11% in 2024 and soared 76.29% in 2025, its largest moves.
• Year by year, Change in Taxes stood at -$1.3 billion in 2022, then sank by 77.23% to -$2.4 billion in 2023, then retreated by 16.23% to -$2.8 billion in 2024, then jumped by 76.29% to -$652.0 million in 2025, then advanced by 19.33% to -$526.0 million in 2026.
• According to Business Quant data, Change in Taxes over the past three periods registered -$526.0 million, -$652.0 million, and -$363.0 million for Q1 2026, Q4 2025, and Q1 2025 respectively.